Pharmacological Treatment of Obsessive-Compulsive Disorder: A Review

Obsessive-Compulsive Disorder: Second Edition

Volumn , Issue , 2003, Pages 43-61

  Zohar, Joseph ^a   Sasson, Yehuda ^a   Chopra, Miriam ^a   Amital, Daniella ^a   Iancu, Iulian ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84979288548     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470861657.ch2     Document Type: Chapter

References (58)

1. Zohar J., Mueller E.A., Insel T.R., Zohar-Kadouch R.C., Murphy D.L. (1987) Serotonergic responsivity in obsessive-compulsive disorder. Comparison of patients and healthy controls. Arch. Gen. Psychiatry, 44: 946-951.
2. Leonard H., Swedo S., Lenane M., Rettew D.C., Cheslow D.L., Hamburger S.D., Rapoport J.L., (1991) A double-blind desipramine substitution during longterm clomipramine treatment in children and adolescents with obsessive-compulsive disorder. Arch. Gen. Psychiatry, 50: 922-927.
3. Ananth J. Pecknold J.C., Van Den Steen N., Engelsman F. (1981) Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis. Progr. Neuropsychopharmacol., 5: 257-262.
4. Volavka J., Neziroglu F., Yaryura-Tobias J.A. (1985) Clomipramine and imipramine in obsessive-compulsive disorder. Psychiatry Res., 14: 85-93.
5. Insel T.R., Mueller E.A., Alterman I., Linnoila M., Murphy D.L. (1985) Obsessive- compulsive disorder and serotonin: is there a connection? Biol. Psychiatry, 20: 1174-1188.
6. Greist J.H., Chouinard G., DuBoff E., Halaris A., Kim S.W., Koran L., Liebowitz M., Lydiard R.B., Rasmussen S., White K. et al (1995) Double-blind parallel comparison of three doses of sertraline and placebo in outpatients with obsessive- compulsive disorder. Arch. Gen. Psychiatry, 52: 289-295.
7. Montgomery S.A., McIntyre A., Osterheider M., Sarteschi P., Zitterl W., Zohar J., Birkett M., Wood A. (1993) A double-blind, placebo controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. Eur. Neuropsychopharmacol., 3: 143-152.
8. Wheadon D.E., Bushnell W.D., Steiner M. (1993) A fixed dose comparison of 20, 40 or 60mg paroxetine to placebo in the treatment of OCD. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Honolulu, December 13-17.
9. Marks I.M., Stern R.S., Mawson D., Cobb J., McDonald R. (1980) Clomipramine and exposure for obsessive-compulsive rituals. Br. J. Psychiatry, 136: 1-25.
10. Montgomery S.A. (1980) Clomipramine in obsessional neurosis: a placebo controlled trial. Pharmacol. Med., 1: 189-192.
11. Thoren P., Asberg M., Gronholm B., Jornestedt L., Traskman L. (1980) Clomipramine treatment of obsessive-compulsive disorder. A controlled clinical trial. Arch. Gen. Psychiatry, 37: 1281-1285.
12. Flament M.F., Rapoport J.L., Berg C.J., Sceery W., Kilts C., Mellstrom B., Linnoila M. (1985) Clomipramine treatment of childhood obsessive-compulsive disorder: a double-blind controlled study. Arch. Gen. Psychiatry, 42: 977-983.
13. Mavissakalian M., Turner S.M., Michelson L., Jacob R. (1985) Tricyclic antidepressants in obsessive-compulsive disorder: antiobsessional or antidepressant agents? Am. J. Psychiatry, 142: 572-576.
14. Zohar J., Insel T. (1987) Obsessive compulsive disorder: psychobiological approaches to diagnosis, treatment and pathophysiology. Biol. Psychiatry, 22: 667-687.
15. Goodman W.K., Price L.H., Rasmussen S.A. (1989) Efficacy of fluvoxamine in obsessive-compulsive disorder: a double-blind comparison of fluvoxamine and placebo. Arch. Gen. Psychiatry, 46: 36-40.
16. Perse T.L., Greist J.H., Jefferson R.H., Rosenfeld R., Dar R. (1987) Fluvoxamine treatment of obsessive-compulsive disorder. Am. J. Psychiatry, 144: 1543-1548.
17. Price L.H., Goodman W.K., Charney D.S., Rasmussen S.A., Heninger G.R. (1987) Treatment of severe obsessive-compulsive disorder with fluvoxamine. Am. J. Psychiatry, 144: 1059-1061.
18. Insel T.R., Alterman I., Murphy D.L. (1982) Antiobsessional and anti-depressant effects of clomipramine in the treatment of obsessive-compulsive disorder. Psychopharmacol. Bull., 18: 115-117.
19. Goodman W.K., Price L.H., Delgado P.L., Palumbo J., Krystal J.H., Nagy L.M., Rasmussen S.A., Heninger G.R., Charney D.S. (1990) Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Arch. Gen. Psychiatry, 47: 577-585.
20. Murphy D.L., Siever L.J., Insel T.R. (1985) Therapeutic responses to tricyclic antidepressants and related drugs in non-affective disorder patient population. Progr. Neuropsychopharmacol. Biol. Psychiatry, 9: 3-13.
21. Fernandez C.E., Lopez-Ibor J.J. (1967) Monochlorimipramine in the treatment of psychiatric patients resistant to other therapies. Actas Luso Esp. Neurol. Psiq. Cienc. Afines, 26: 119-147.
22. DeVeaugh Geiss J., Landau P., Katz R. (1989) Treatment of obsessive-compulsive disorder with clomipramine. Psychiatr. Ann., 19: 97-101.
23. Clomipramine Collaborative Study Group (1991) Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch. Gen. Psychiatry, 48: 730-738.
24. Tollefson G.D., Rampey A.H., Potvin J.H. (1994) A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch. Gen. Psychiatry, 51: 559-567.
25. Jenike M.A., Hyman S., Baer L., Holland A., Minichiello W.E., Buttolph L., Summergrad P., Seymour R., Ricciardi J. (1990) A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory. Am. J. Psychiatry, 147: 1209-1215.
26. Koran L.M., McElroy S.L., Davidson J.R.T., Rasmussen S.A., Hollander E., Jenike M.A. (1996) Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparison. J. Clin. Psychopharmacol., 16: 121-129.
27. Mallya G.K., White, K., Waternaux C., Quay S. (1992) Short and long-term treatment of OCD with fluvoxamine. Ann. Clin. Psychiatry, 4: 77-80.
28. Chouinard G., Goodman W., Greist J., Jenike M., Rasmussen S., White K., Hackett E., Gaffney M., Bick P. (1990) Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive-compulsive disorder. Psychopharmacol. Bull., 26: 279-284.
29. Greist J.H., Jefferson J.W., Kobak K.A., Chouinard G., DuBoff E., Halaris A., Kim S.W., Koran L., Liebowitz M.R., Lydiard B. et al (1995) A 1 year doubleblind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int. Clin. Psychopharmacol., 10: 57-65.
30. Steiner M., Oakes R., Gergel I.P., Wheadon D.E. (1994) Predictors of response to paroxetine therapy in OCD. Presented at the American Psychiatric Association Annual Meeting, Philadelphia, May 21-26.
31. Zohar J., Judge R. (1996) Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. Br. J. Psychiatry, 169: 468-474.
32. Montgomery S.A. (1998) Citalopram treatment of obsessive-compulsive disorder:results from a double-blind, placebo-controlled trial. Presented at the Annual Meeting of the American College of Neuropsychopharmacology, Puerto Rico, December 14-18.
33. Montgomery S.A., Henry J., McDonald G., Dinan T., Lader M., Hinmarch I., Clare A., Nutt D. (1994) Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int. Clin. Psychopharmacol., 9: 47-53.
34. Kasper S., Note I.D., Montgomery S.A. (1999) Citalopram treatment of obsessive- compulsive disorder: results from a double-blind placebo-controlled study. Eur. Neuropsychopharmacol., 9 (suppl. 5): S217-S218.
35. Bisserbe J.C., Lane R.M., Flament M., and the Franco-Belgian Study Group (1997) A double-blind comparison of sertraline and clomipramine in outpatients with obsessive-compulsive disorder. Eur. Psychiatry, 12: 82-93.
36. Pato M.T., Zohar-Kadouch R., Zohar J., Murphy D.L. (1988) Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am. J. Psychiatry, 145: 1521-1525.
37. Pitman R.K., Green R.C., Jenike M.A., Mesulam M.M. (1987) Clinical comparison of Tourette's disorder and obsessive-compulsive disorder. Am. J. Psychiatry, 144: 1166-1171.
38. Leckman J.F., Grice D.E., Barr L.C., deVries A.L.C., Martin C., Cohen D.J., McDougle C.J., Goodman W.K., Rasmussen S.A. (1995) Tic-related vs. nontic- related obsessive-compulsive disorder. Anxiety, 1: 208-215.
39. Leckman J.F., Goodman W.K., North W.G., Chappell R.B., Price L.H., Pauls D.L., Anderson G.M., Riddle M.A., McSwiggan-Hardin M., McDougle C.J. et al (1994) Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder: comparison with Tourette's syndrome and healthy controls. Arch. Gen. Psychiatry, 51: 782-792.
40. Como P. (1995) Obsessive-compulsive disorder in Tourette's syndrome. In Behavioral Neurology of Movement Disorders (Eds W.J. Weiner, A.E. Lang), pp. 281-291, Raven Press, New York.
41. McDougle C.J., Goodman W.K., Price L.H., Delgado P.L., Krystal J. H., Charney D.S., Heninger G.R. (1990) Neuroleptic addition in fluvoxamine-refractory obsessive-compulsive disorder. Am. J. Psychiatry, 147: 652-654.
42. Berman I., Kalinowski A., Berman S.M., Lengua J., Green A.L. (1995) Obsessive and compulsive symptoms in chronic schizophrenia. Compr. Psychiatry, 36: 6-10.
43. Fenton W.S., McGlashan T.H. (1986) The prognostic significance of obsessivecompulsive symptoms in schizophrenia. Am. J. Psychiatry, 43: 437-441.
44. Siris S.G., van Kammen D.P., Docherty G.P. (1978) Use of antidepressant drugs in schizophrenia. Arch. Gen. Psychiatry, 35: 1368-1377.
45. Dufresne R.L., Kass D.J., Becker R.E. (1988) Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia. Drug Develop. Res., 12: 259-266.
46. Siris S.G., Morgan V., Fagerstrom R., Rifkin A., Cooper T.B. (1987) Adjunctive imipramine in the treatment of post-psychotic depression in schizophrenia: a controlled trial. Arch. Gen. Psychiatry, 44: 533-539.
47. Siris S.G., Bermanzohn P.C., Mason S.E., Shuwall M.A. (1994) Maintenance imipramine for secondary depression in schizophrenia: a controlled trial. Arch. Gen. Psychiatry, 51: 109-115.
48. Zohar J., Kaplan Z., Benjamin J. (1993) Clomipramine treatment of obsessivecompulsive symptomatology in schizophrenic patients. J. Clin. Psychiatry, 54: 385-388.
49. Berman I., Sapers B.H., Chang H.H.G., Losonczy M.F., Schmilder J., Green A.I. (1995) Treatment of obsessive-compulsive symptomatology in schizophrenic patients with clomipramine. J. Clin. Psychopharmacol., 15: 206-210.
50. van Praag H., Kahn R.S., Asnis G.M., Wetzler S., Brown S.L., Bleich A., Korn M.L. (1987) Denosologization of biological psychiatry. J. Affect. Disord., 13: 1-8.
51. Swedo S.E., Leonard H., Shapiro M.B., Casey B.J., Mannheim G.B., Lenane M., Rettew D.C. (1993) Sydenham's chorea: physical and psychological symptoms of St. Vitus' dance. Paediatrics, 91: 706-713.
52. Roy B.F., Benkelfat C., Hill J.L., Pierce P.F., Dauphin M.M., Kelly T.M., Sunderland T., Weinberger D.R., Breslin N. (1994) Serum antibody for somatostatin 14 and prodynorphin 209-240 in patients with obsessive-compulsive disorder, schizophrenia, Alzheimer's disease, multiple sclerosis and advanced HIV infection. Biol. Psychiatry, 35: 335-344.
53. Perlmutter S.J., Leitman S.F., Garvey M.A., Hamburger S., Feldman E., Leonard H.L., Swedo S.E. (1999) Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood. Lancet, 354: 1153-1158.
54. Ravizza L., Barzega G., Bellino S., Bogetto F., Maina G. (1996) Therapeutic effect and safety of adjunctive risperidone in refractory obsessive-compulsive disorder (OCD). Psychopharmacol. Bull., 32: 677-682.
55. Dannon P.N., Sasson Y., Hirschmann S., Iancu I., Grunhaus L.J., Zohar J. (2000) Pindolol augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind placebo controlled trial. Eur. Neuropsychopharmacol., 10: 165-169.
56. McDougle C.J., Price L.H., Goodman W.K., Charney D.S., Heninger F.R. (1991) A controlled trial of lithium augmentation in fluvoxamine-refractory obsessive-compulsive disorder: lack of efficacy. J. Clin. Psychopharmacol., 11: 175-181.
57. Pigott T.A., L'Heureux F., Rubenstein C.S., Bernstein S.E., Hill J.L., Murphy D.L. (1992) A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder. J. Clin. Psychopharmacol., 12: 156-162.
58. Pigott T.A., Pato M., L'Heureux F. (1991) A controlled comparison of adjuvant lithium carbonate or thyroid hormone in clomipramine-treated OCD patients. J. Clin. Psychopharmacol., 11: 245-248.